These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9112974)

  • 1. Acute effects of blood glucose on chromatic visually evoked potentials in persons with diabetes and in normal persons.
    Schneck ME; Fortune B; Switkes E; Crognale M; Adams AJ
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):800-10. PubMed ID: 9112974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatic and achromatic visual evoked potentials in Parkinson's disease.
    Büttner T; Kuhn W; Müller T; Heinze T; Pühl C; Przuntek H
    Electroencephalogr Clin Neurophysiol; 1996 Sep; 100(5):443-7. PubMed ID: 8893662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways.
    Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC
    Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color visual evoked potentials in children with type 1 diabetes: relationship to metabolic control.
    Elia YT; Daneman D; Rovet J; Abdolell M; Lam WC; Till C; Erraguntla V; Rubab S; Lodha N; Westall CA
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4107-13. PubMed ID: 16249487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccadic eye movement and visual pathways function in diabetic patients.
    Alessandrini M; Bruno E; Parisi V; Uccioli L; Giacomini PG
    An Otorrinolaringol Ibero Am; 2001; 28(3):269-80. PubMed ID: 11455884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic short-wavelength sensitivity: variations with induced changes in blood glucose level.
    Volbrecht VJ; Schneck ME; Adams AJ; Linfoot JA; Ai E
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1243-6. PubMed ID: 8125735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual evoked potentials in infants of diabetic mothers: relations to clinical and metabolic status during pregnancy and delivery.
    Brinciotti M; Matricardi M; Colatrella A; Torcia F; Fallucca F; Napoli A
    Clin Neurophysiol; 2009 Mar; 120(3):563-8. PubMed ID: 19181572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual evoked responses in diabetes.
    Millingen KS; Yeo PT; Kamaldeen S
    Clin Exp Neurol; 1987; 24():153-8. PubMed ID: 3268341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential aging of chromatic and achromatic visual pathways: behavior and electrophysiology.
    Page JW; Crognale MA
    Vision Res; 2005 May; 45(11):1481-9. PubMed ID: 15743617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red-green chromatic mechanisms in normal aging and glaucomatous observers.
    Karwatsky P; Overbury O; Faubert J
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2861-6. PubMed ID: 15277514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatic VEP assessment of human macular pigment: comparison with minimum motion and minimum flicker profiles.
    Robson AG; Holder GE; Moreland JD; Kulikowski JJ
    Vis Neurosci; 2006; 23(2):275-83. PubMed ID: 16638178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient VEP and psychophysical chromatic contrast thresholds in children and adults.
    Boon MY; Suttle CM; Dain SJ
    Vision Res; 2007 Jul; 47(16):2124-33. PubMed ID: 17568648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in vernier evoked cortical potential with age.
    Li RW; Edwards MH; Brown B
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1119-24. PubMed ID: 11274094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy.
    Gregori B; Galié E; Pro S; Clementi A; Accornero N
    Neurol Sci; 2006 Nov; 27(5):323-7. PubMed ID: 17122941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of human retinotopic visual cortex to S-cone-opponent, L/M-cone-opponent and achromatic stimulation.
    Mullen KT; Dumoulin SO; McMahon KL; de Zubicaray GI; Hess RF
    Eur J Neurosci; 2007 Jan; 25(2):491-502. PubMed ID: 17284191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent substitution S-cone electroretinogram in subjects with diabetes mellitus.
    Mortlock KE; Chiti Z; Drasdo N; Owens DR; North RV
    Ophthalmic Physiol Opt; 2005 Sep; 25(5):392-9. PubMed ID: 16101944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and dichromatic color discrimination measured with transient visual evoked potential.
    Gomes BD; Souza GS; Rodrigues AR; Saito CA; Silveira LC; da Silva Filho M
    Vis Neurosci; 2006; 23(3-4):617-27. PubMed ID: 16962005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient tritanopia in migraine: evidence for a large-field retinal abnormality in blue-yellow opponent pathways.
    Tibber MS; Shepherd AJ
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5125-31. PubMed ID: 17065534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for photoreceptor changes in patients with diabetic retinopathy.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2355-65. PubMed ID: 9344359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
    Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.